146 related articles for article (PubMed ID: 28511371)
1. Study of Serum Total PSA and Free PSA as an Oncological Marker in Breast Tumour.
Jahir ET; Devi R; Borthakur BB
J Clin Diagn Res; 2017 Mar; 11(3):BC13-BC16. PubMed ID: 28511371
[TBL] [Abstract][Full Text] [Related]
2. Serum total PSA and free PSA in breast tumors.
Dash P; Pati S; Mangaraj M; Sahu PK; Mohapatra PC
Indian J Clin Biochem; 2011 Apr; 26(2):182-6. PubMed ID: 22468047
[TBL] [Abstract][Full Text] [Related]
3. Percent free PSA as an additional measure in a prostate cancer screen.
Miele ME
Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
[TBL] [Abstract][Full Text] [Related]
4. The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy men.
Lein M; Koenig F; Jung K; McGovern FJ; Skates SJ; Schnorr D; Loening SA
Br J Urol; 1998 Aug; 82(2):231-6. PubMed ID: 9722758
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer.
Björk T; Lilja H; Christensson A
BJU Int; 1999 Dec; 84(9):1021-7. PubMed ID: 10571627
[TBL] [Abstract][Full Text] [Related]
6. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
Haese A; Graefen M; Steuber T; Becker C; Pettersson K; Piironen T; Noldus J; Huland H; Lilja H
Prostate; 2001 Oct; 49(2):101-9. PubMed ID: 11582588
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients.
Minardi D; Galosi AB; Recchioni A; Giammarco L; Polito M; Muzzonigro G
Urol Int; 2001; 67(4):272-82. PubMed ID: 11741128
[TBL] [Abstract][Full Text] [Related]
8. Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?
Djavan B; Shariat S; Ghawidel K; Güven-Marberger K; Remzi M; Kovarik J; Hoerl WH; Marberger M
Urology; 1999 Jun; 53(6):1169-74. PubMed ID: 10367847
[TBL] [Abstract][Full Text] [Related]
9. Effect of NIH-IV prostatitis on free and free-to-total PSA.
Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
[TBL] [Abstract][Full Text] [Related]
10. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
[TBL] [Abstract][Full Text] [Related]
11. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the diagnostic use of free prostate specific antigen/total prostate specific antigen ratio in detecting prostate cancer.
Iqbal N; Chaughtai N
J Pak Med Assoc; 2005 Aug; 55(8):318-20. PubMed ID: 16164156
[TBL] [Abstract][Full Text] [Related]
13. Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.
Okegawa T; Kinjo M; Ohta M; Miura I; Horie S; Nutahara K; Higashihara E
Int J Urol; 2003 Apr; 10(4):201-6. PubMed ID: 12657099
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.
Okegawa T; Noda H; Nutahara K; Higashihara E
Eur Urol; 2000 Oct; 38(4):380-7. PubMed ID: 11025374
[TBL] [Abstract][Full Text] [Related]
15. Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer.
Stimac G; Spajic B; Reljic A; Katusic J; Popovic A; Grubisic I; Tomas D
Korean J Urol; 2014 Aug; 55(8):527-32. PubMed ID: 25132947
[TBL] [Abstract][Full Text] [Related]
16. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
[TBL] [Abstract][Full Text] [Related]
17. Serum level of prostate-specific antigen (PSA) in women with breast cancer.
Mashkoor FC; Al-Asadi JN; Al-Naama LM
Cancer Epidemiol; 2013 Oct; 37(5):613-8. PubMed ID: 23932967
[TBL] [Abstract][Full Text] [Related]
18. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
Douglas TH; Morgan TO; McLeod DG; Moul JW; Murphy GP; Barren R; Sesterhenn IA; Mostofi FK
Cancer; 1997 Jul; 80(1):107-14. PubMed ID: 9210715
[TBL] [Abstract][Full Text] [Related]
19. Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations.
Veltri RW; Miller MC
Urology; 1999 Apr; 53(4):736-45. PubMed ID: 10197849
[TBL] [Abstract][Full Text] [Related]
20. [A preliminary study of PSA level in 646 healthy men in Beijing].
Shao Q; Guo Y; Guo H
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):591-2. PubMed ID: 11798824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]